Five9 reports its Q1 2026 results after the close today, and the stock walks into the print with a sharply different complexion than it carried a month ago.
Short sellers have been cutting exposure for weeks. SI % FF has dropped from around 8.8% in mid-March to 7.8% now — an 11% decline over the past month, with a further 4.5% fall this week alone. That move is consistent with the 18% price recovery FIVN has staged over the same period, trading at $17.05 as of Wednesday's close. Whether the short covering is genuine conviction or pre-earnings risk reduction is the question sitting underneath tonight's release.
The options market is telling a more bullish story than the shorts. The put/call ratio is running at 0.21 — well below its 20-day average of 0.23 and just above the 52-week low of 0.20 hit earlier this week. That's more than one standard deviation below normal, pointing to notably elevated call activity relative to puts. This is the leanest protection market has sought on FIVN in a year, and it sits in sharp contrast to the 52-week high PCR of 1.41, which captured a period of deep pessimism around the stock. The borrow market adds little drama: cost to borrow has eased 9% on the week to just 0.42%, and availability is wide, meaning the lending pool is far from stressed. There is no squeeze setup here — shorts who want to cover can do so cheaply.
The Street is broadly positive but has spent most of the year trimming targets. After last quarter's print in February, analysts maintained their ratings but cut targets across the board — Barclays stayed Overweight but moved its target from $25 to $22 in mid-April, the only genuinely recent move in the dataset. The consensus mean target is $26.90, implying 58% upside from the current price, which reflects how far the stock has fallen from where analysts were comfortable underwriting it. The bull case rests on Enterprise AI momentum — 50% revenue growth in that segment and ~80% AI bookings growth for three consecutive quarters — alongside an accelerating mix shift toward subscription revenue (now 82% of total). The bear case centres on a DNR rate that has slipped to 105%, macro-driven sales cycle elongation, and the ongoing compression of software multiples as AI disruption fears hang over the contact-centre space. On valuation, the EV/EBITDA multiple sits near 4.5x, with the P/E at roughly 5x — numbers that look undemanding if the growth narrative holds.
One institutional thread worth noting: both Vanguard and BlackRock added to their positions in Q1 (Vanguard increasing by 759,000 shares to 13.1% of outstanding), while Voss Capital — the third-largest holder at 8.1% — last reported in December and has not updated. A cluster of insider sells in early March, involving the President, CFO, and several C-suite officers at prices between $17.70 and $17.98, was modest in scale and showed no signs of urgency. The stock trades near those same prices today, which means insiders who sold then are roughly flat rather than vindicated.
The last earnings print — in February — produced a one-day gain of 15.5% and a five-day gain of 11.8%, an unusually strong post-results move for a stock that had been heavily under pressure. Tonight's setup — shorts trimmed, calls dominating options activity, peers like CRM and HUBS each down 4-5% on the week while FIVN held its ground — makes the read-through from the last print the natural reference point. What to watch is whether the AI bookings trajectory sustains its run rate, and whether DNR shows any sign of stabilising — those two numbers, more than revenue headline, are where the bull-bear debate gets resolved.
See the live data behind this article on ORTEX.
Open FIVN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
